CFDE Data Portal | Search FGF13

	Label	Description
	FGF13 associations Collection (Entity type)	Associations for FGF13_associations
	FGF13 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	FGF13-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	FGF13-AS1 associations Collection (Entity type)	Associations for FGF13-AS1_associations
	FGF13 Gene (Entity type)	ENSG00000129682 - fibroblast growth factor 13
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE242555 1 V 0 NICOTINAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 5 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

FGF13 associations

Associations for FGF13_associations

FGF13 associations.tsv

A file from IDG as part of the Harmonizome project

FGF13-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

FGF13-AS1 associations

Associations for FGF13-AS1_associations

FGF13

ENSG00000129682 - fibroblast growth factor 13

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn

A Gene Set from LINCS

GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN

A Gene Set from LINCS

GSE242555 1 V 0 NICOTINAMIDE HUMAN DN

A Gene Set from LINCS

GSE172016 2 V 5 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.